Search Results - Adele K. Fielding
- Showing 1 - 4 results of 4
-
1
Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignancies by Richard Burt, Dana Warcel, Adele K. Fielding
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity by Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Sam Salek
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study by Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Magda J. Al-Obaidi, Metod Oblak, Sam Salek
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO by Pushpendra Goswami, Esther N. Oliva, Tatyana Ionova, Roger Else, Jonathan Kell, Adele K. Fielding, Daniel M. Jennings, Marina Karakantza, Saad Al-Ismail, Graham P. Collins, Stewart McConnell, Catherine Langton, Magda J. Al-Obaidi, Metod Oblak, Sam Salek
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book